Skip to content

Twist Bioscience Corporation TWST Common stock, capital shares reserved for future issuance

Common stock, capital shares reserved for future issuance at other companies

Danaher logo
DanaherDHR

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$5.45B+24.4%
Enterprise value$5.44B+30.4%
P/S13.3×+0.7×

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept us-gaap:CommonStockCapitalSharesReservedForFutureIssuance.

The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Twist Bioscience Corporation's common stock, capital shares reserved for future issuance.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Twist Bioscience Corporation's common stock, capital shares reserved for future issuance?
Twist Bioscience Corporation (TWST) reported common stock, capital shares reserved for future issuance of $861K in Q1 2026.
How has Twist Bioscience Corporation's common stock, capital shares reserved for future issuance changed year-over-year?
Twist Bioscience Corporation's common stock, capital shares reserved for future issuance increased by 8.3% year-over-year, from $795K to $861K.
What is the long-term trend for Twist Bioscience Corporation's common stock, capital shares reserved for future issuance?
Over 4 years (2021 to 2025), Twist Bioscience Corporation's common stock, capital shares reserved for future issuance has grown at a 19.2% compound annual growth rate (CAGR), from $355K to $716K.